Skip to main content

ALLURION TECHNOLOGIES, INC.

For the period ended Mar 31, 2026. Filed May 15, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 15, 2026

ALUR$0.67-5.6%Stored close · as of Mar 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

The following list of exhibits includes exhibits submitted with this Quarterly Report on Form 10-Q as filed with the SEC and those incorporated by reference to other filings.

ExhibitNumberDescriptionIncorporated by Reference herein from - Form or ScheduleFile NumberExhibitFiled Date
3.1Amended and Restated Certificate of Incorporation of Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.)8-K001-417673.1August 7, 2023
3.2Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Allurion Technologies, Inc.8-K001-417673.1December 31, 2024
3.3Bylaws of Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.)8-K001-417673.2August 7, 2023
4.1Warrant Agreement, dated February 4, 2021, between Compute Health Acquisition Corp. and Continental Stock Transfer & Trust Company, as warrant agent.8-K001-400014.1February 9, 2021
4.2Amendment to Warrant Agreement, dated August 1, 2023, by and between Compute Health and Continental Stock Transfer & Trust Company.8-K001-417674.2August 7, 2023
4.3Warrant Assignment, Assumption and Amendment Agreement, dated August 1, 2023, by and among Compute Health Acquisition Corp., New Allurion Holdings, Inc., and Continental Stock Transfer & Trust Company.8-K001-417674.3August 7, 2023
4.4Description of Capital Stock.10-K/A001-417674.4August 19, 2025
4.5Form of Public Warrant.8-K001-417674.1July 1, 2024
4.6Form of Private Placement Warrant.8-K001-417674.2July 1, 2024
4.7Form of Common Warrant (January 2025).8-K001-417674.1January 28, 2025
4.8Form of Common Warrant (February 2025).8-K001-417674.1February 21, 2025
4.9Form of Private Placement Warrant (February 2025).8-K001-417674.2February 21, 2025
4.10Form of Private Placement Warrant (November 2025).8-K001-417674.1November 12, 2025
4.11Form of New Warrant.8-K001-417674.1February 25, 2026
10.1Form of Inducement Letter.8-K001-4176710.1February 25, 2026
31.1*Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
  • Filed herewith.

** Furnished herewith

Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.